|
|
|
|
| LEADER |
01439nam a2200325 u 4500 |
| 001 |
EB000944429 |
| 003 |
EBX01000000000000000738019 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 0309086264
|
| 020 |
|
|
|a 9780309086264
|
| 245 |
0 |
0 |
|a An assessment of the CDC anthrax vaccine safety and efficacy research program
|h Elektronische Ressource
|c Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, Medical Follow-up Agency, Institute of Medicine of The National Academies
|
| 246 |
3 |
1 |
|a CDC anthrax vaccine safety and efficacy research program
|
| 260 |
|
|
|a Washington, DC
|b National Academies Press
|c 2003, c2003
|
| 300 |
|
|
|a xvii, 160 p.
|c 23 cm
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Drug Evaluation
|
| 653 |
|
|
|a Program Evaluation
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Anthrax / prevention & control
|
| 653 |
|
|
|a Anthrax Vaccines
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 015 |
|
|
|a GBA3-15358
|
| 856 |
4 |
0 |
|u http://www.nap.edu/books/0309086264/html
|3 Volltext
|n Provider site
|3 Volltext
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK221080
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 615.372
|
| 082 |
0 |
|
|a 610
|